Skip to main content
main-content

09-11-2017 | ACR/ARHP 2017 | Video

Expert commentary: Biologic use during pregnancy and infection risk in infants

Bonnie Bermas provides an independent viewpoint on the results of a study suggesting that the use of biologic agents by women with rheumatoid arthritis during pregnancy is not associated with an increased serious infection risk for their babies.

Read the accompanying news story